Inequalities in prescription rates of anti-osteoporosis drugs in primary care in England: Apractice-level prescribing data analysis in 2013-2018.
Targeting Macrophages: Friends or Foes in Disease? Front Pharmacol.
Silicon substituted hydroxyapatite/VEGF scaffolds stimulate bone regeneration in osteoporotic sheep.
Bile acids and bilirubin effects on osteoblastic gene profile.Implications in the pathogenesis of osteoporosis in liver diseases.
Spanish National Hip Fracture Registry (RNFC): First-year results and comparison with other registries and prospective multi-centric studies from Spain].
Efficacy and safety of denosumab vs.bisphosphonates in postmenopausal women previously treated with oral bisphosphonates.
Cholecalciferol and calcifediol for vitamin D supplementation.
Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures.
Long term effects on biochemical bone markers of a single infusion of zoledronic acid in Paget disease of bone.
